| Vildagliptin Carboxylic Acid |
维格列汀羧酸 |
565453-40-9 |
| Vildagliptin Carboxy Acid Metabolite Trifluoroacetate |
维达列汀羧基酸代谢物三氟醋酸盐 |
565453-41-0 |
| EXECUTE STANDARD |
替米沙坦甲酯 |
528560-93-2 |
| Rosuvastatin Related Compound 6 |
Rosuvastatin Related Compound 6 |
521973-99-9 |
| tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
瑞舒伐他汀杂质 |
521974-00-5 |
| 4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine,hexahydro-3a,5,5-triMethyl-a-(2-Methylpropyl)-N,N-bis(triMethylsilyl)-,(aR,3aS,4S,6S,7aR)- |
4,6-Methano-1,3,2-benzodioxaborole-2-MethanaMine,hexahydro-3a,5,5-triMethyl-a-(2-Methylpropyl)-N,N-bis(triMethylsilyl)-,(aR,3aS,4S,6S,7aR)- |
514820-48-5 |
| Formoterol Fumarate Dihydrate EP Impurity I |
福莫特罗EP杂质I |
532414-36-1 |
| Rapamycin Impurity 6 |
Rapamycin Impurity 6 |
500733-49-3 |
| 2-(N-benzyl-N-methylamino)ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate |
脱氢尼卡地平 |
59875-58-0 |
| 10-methoxy-4-(1-methylpiperidin-4-yl)-4H-benzo[4.5]cyclohepta[1,2-b]thiophene-4-ol |
10-甲氧基-4-(1-甲基-4-哌啶基)-4H-苯并[4,5]环庚三烯并[1,2-B]噻吩-4-醇 |
59743-88-3 |
| (endo,anti)-(±)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide |
异丙托溴铵相关物质B |
58073-59-9 |
| (R)-(+)-1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLIC ACID |
依托咪酯EP杂质A |
56649-48-0 |
| 6-hydroxydexamethasone |
6-羟基地塞米松 |
55879-47-5 |
| (6R-cis)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
头孢西丁EP杂质A |
54333-94-7 |
| N-ADAMANTAN-1-YL-2-CHLORO-ACETAMIDE |
1-氯乙酰氨基金刚烷 |
5689-59-8 |
| Palonosetron Impurity 9 |
帕洛诺司琼杂质 9 |
2216755-75-6 |
| Macitentan Impurity 16 |
马西替坦杂质16 |
2211054-17-8 |
| Rivaroxaban Impurity 11 |
利伐沙班杂质 11 |
1411775-06-8 |
| Milnacipran Impurity 4 |
Milnacipran Impurity 4 |
1353644-49-1 |
| 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1), rel- |
莫西沙星消旋体 |
1346603-25-5 |
